Angle

Medical diagnostics company with products in the cancer diagnostics and fetal health markets.

Launch date

Jan 1994

Employees

Market cap

Enterprise valuation

AUD50m (Public information from Sep 2024)

Company register number 10087031

Guildford England (HQ)

http://angleplc.com

https://twitter.com/parsortix https://www.linkedin.com/company/angle-technology

View job openings

Revenues, earnings & profits over time

GBP	2020	2021	2022	2023	2024	2025	2026
Revenues	<1m	1.0m	1.0m	2.2m	8.3m	17.2m	36.1m
% growth	-	33 %	3 %	110 %	277 %	108 %	110 %
EBITDA	(12.2m)	(15.7m)	(21.2m)	(18.9m)	(14.8m)	(12.5m)	(3.1m)
% EBITDA margin	(1606 %)	(1552 %)	(2040 %)	(865 %)	(179 %)	(73 %)	(9 %)
Profit	(11.6m)	(15.0m)	(21.7m)	(20.1m)	(15.8m)	(13.8m)	(5.8m)
% profit margin	(1523 %)	(1482 %)	(2083 %)	(921 %)	(192 %)	(81 %)	(16 %)
EV / revenue	97.3x	244.6x	95.7x	6.6x	5.3x	2.5x	1.2x
EV / EBITDA	-6.1x	-15.8x	-4.7x	-0.8x	-3.0x	-3.4x	-14.1x
R&D budget	3.7m	3.4m	4.5m	2.5m	-	-	-
R&D % of revenue	480 %	340 %	431 %	113 %	-	-	-

Date	Investors	Amount	Round
Mar 2015	N/A	$250k	Early VC
Nov 2016	N/A	N/A	IPO
Oct 2020	N/A	£20.0m	Post IPO Equity
Jul 2022*	N/A	£20.1m	Post IPO Equity
Jun 2024*	N/A	£500k	Post IPO Equity
Total Funding		AUD386k

Tech stackLearn more about the technologies and tools that this company uses.

MyVox Ultrasonics